Professor | Bing Du | Asia Growth Partners

Name	Bing Du
Contact Information	bdu@bio.ecnu.edu.cn
Language ability	Chinese, English
Province	Shanghai

Name

Bing Du

Contact Information

bdu@bio.ecnu.edu.cn

Language ability

Chinese, English

Province

Shanghai

University/Lab Affiliation and Title	East China Normal University
Faculty	Life Sciences
Academic Background & Achievements	2001-2006: PhD in Biochemistry and Molecular Biology, East China Normal University 1997-2001: Bachelor in Biochemistry, Anhui University Notable achievements include various awards for excellence in teaching and research.
Work Experience	2006-present: Faculty at School of Life Sciences, East China Normal University 2007-2009: Visiting Scholar at Texas A&M University Health Science Center, USA
Awards	Shanghai Outstanding Academic/Technical Leader Morning Light Scholar of Shanghai East China Normal University Outstanding Communist Party Member East China Normal University Graduate Excellence Education Award East China Normal University Excellent Innovation and Entrepreneurship Instructor

University/Lab Affiliation and Title

East China Normal University

Faculty

Life Sciences

Academic Background & Achievements

2001-2006: PhD in Biochemistry and Molecular Biology, East China Normal University
1997-2001: Bachelor in Biochemistry, Anhui University
Notable achievements include various awards for excellence in teaching and research.

Work Experience

2006-present: Faculty at School of Life Sciences, East China Normal University
2007-2009: Visiting Scholar at Texas A&M University Health Science Center, USA

Awards

Shanghai Outstanding Academic/Technical Leader
Morning Light Scholar of Shanghai
East China Normal University Outstanding Communist Party Member
East China Normal University Graduate Excellence Education Award
East China Normal University Excellent Innovation and Entrepreneurship Instructor

Areas of Focus	Regulation of tumor immune microenvironment and tumor immunotherapy Innovative construction and application research of CAR-T cells
Publications	FFAR2 expressing myeloid-derived suppressor cells drive cancer immunoevasion, Bing Du et al., 2024 Allogeneic CAR-T cells with of HLA-A/B and TRAC disruption exhibit promising antitumor capacity against B cell malignancies, Bing Du et al., 2024 LIGHT/TNFSF14 promotes CAR-T cell trafficking and cytotoxicity through reversing immunosuppressive tumor microenvironment, Bing Du et al., 2023 Non-viral, specifically targeted CAR-T cells achieve high safety and efficacy in B-NHL, Bing Du et al., 2022 Multi-omics analysis for potential inflammation-related genes involved in tumour immune evasion via extended application of epigenetic data, Bing Du et al., 2022 Neuroendocrine Regulation of Stress-Induced T Cell Dysfunction during Lung Cancer Immunosurveillance via the Kisspeptin/GPR54 Signaling Pathway, Bing Du et al., 2022 Multi-Omics Analysis for Transcriptional Regulation of Immune-Related Targets Using Epigenetic Data: A New Research Direction, Bing Du et al., 2022 Inflammatory macrophages exacerbate neutrophil-driven joint damage through ADP/P2Y1 signaling in rheumatoid arthritis, Bing Du et al., 2022 Cross-neutralization of RBD mutant strains of SARS-CoV-2 by convalescent patient derived antibodies, Bing Du et al., 2021 Blocking P2X7-Mediated Macrophage Polarization Overcomes Treatment Resistance in Lung Cancer, Bing Du et al., 2020

Areas of Focus

Regulation of tumor immune microenvironment and tumor immunotherapy
Innovative construction and application research of CAR-T cells

Publications

FFAR2 expressing myeloid-derived suppressor cells drive cancer immunoevasion, Bing Du et al., 2024
Allogeneic CAR-T cells with of HLA-A/B and TRAC disruption exhibit promising antitumor capacity against B cell malignancies, Bing Du et al., 2024
LIGHT/TNFSF14 promotes CAR-T cell trafficking and cytotoxicity through reversing immunosuppressive tumor microenvironment, Bing Du et al., 2023
Non-viral, specifically targeted CAR-T cells achieve high safety and efficacy in B-NHL, Bing Du et al., 2022
Multi-omics analysis for potential inflammation-related genes involved in tumour immune evasion via extended application of epigenetic data, Bing Du et al., 2022
Neuroendocrine Regulation of Stress-Induced T Cell Dysfunction during Lung Cancer Immunosurveillance via the Kisspeptin/GPR54 Signaling Pathway, Bing Du et al., 2022
Multi-Omics Analysis for Transcriptional Regulation of Immune-Related Targets Using Epigenetic Data: A New Research Direction, Bing Du et al., 2022
Inflammatory macrophages exacerbate neutrophil-driven joint damage through ADP/P2Y1 signaling in rheumatoid arthritis, Bing Du et al., 2022
Cross-neutralization of RBD mutant strains of SARS-CoV-2 by convalescent patient derived antibodies, Bing Du et al., 2021
Blocking P2X7-Mediated Macrophage Polarization Overcomes Treatment Resistance in Lung Cancer, Bing Du et al., 2020

Tumor Immune Microenvironment Car-T Cell Therapy Immunotherapy Gene Editing Clinical Research Inflammation Cancer

Songcheng Zhu - Tongji University

Haiyun Wang - Tongji University

Yi Xiao - Shanghai Jiao Tong University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us